Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors

Industry Veteran with Business Development and Transactional Expertise Joins Eiger Board of Directors

19-Aug-2009 - USA

Eiger BioPharmaceuticals, Inc. announced the appointment of Paul Truexto its Board of Directors.

Truex is the founder, President and CEO of Anthera Pharmaceuticals - a private pharmaceutical company focused on the development of anti-inflammatory products for life threatening cardiovascular and pulmonary diseases. Previously he was Founder, President and CEO of Peninsula Pharmaceuticals where he negotiated both of Peninsula's anti-infective product agreements with Shionogi & Co. Ltd. and Takeda Chemical Industries respectively. Peninsula was acquired by Johnson & Johnson in 2005 for US$ 245 million. Previously, Mr. Truex held positions at Versicor (Vicuron), which was acquired by Pfizer for US$ 1.9 billion, and at Eli Lilly. Mr. Truex obtained his M.B.A. in Marketing and Finance from Indiana University and a B.A. Degree in International Economics from the University of Waterloo.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances